cardiovascular complication services
-
Cardiotoxicity Services
dying from cardiovascular complication, rather than cancer. In 2016, the European Society of Cardiology (ESC) established a task force of KOLs, raising the urgent need to evaluate the impact of anticancer drugs on cardiotoxicity linked morbidity and mortality. This led to the 2016 ESC position paper developed ...
By Genome Biologics based in Frankfurt am Main, GERMANY.
-
FMSF–PORH Test Services
The first test implemented by Angionica is the FMSF–PORH test (Flow Mediated Skin Fluorescence–Post-Occlusive Reactive Hyperemia), which is used to assess microvascular circulation (vascular endothelial function) based on circulatory stimulation in response to induced reactive hyperemia (PORH). The test makes it possible to assess levels of both contraction and vasodilation and to ...
By Angionica Ltd. based in Lodz, POLAND.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you